XPH TCM - Banlangen Has Been Approved to Enter the UK Market

Recently, a wholly owned subsidiary Xiangcam TCM Research Centre Limited received notice from the MHRA, submitted to the MHRA that radix isatidis products used to treat cold and flu registration approved by the review, as the first declaration of traditional Chinese medicine according to requirements of the eu directive, XPH digital Chinese medicine formally entered the international market, is also a milestone in the development of Chinese traditional Chinese medicine internationalization. This product is the first Chinese medicine product to be registered and approved by MHRA in the UK for the treatment of colds.